What the results of Wegovy’s longest clinical trial yet show about ...
May 13, 2024 · New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight loss and...
FDA Approves First Treatment to Reduce Risk of Serious Heart …
“Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight,”...
Weight-loss drug Wegovy cuts risk of stroke, heart attacks ... - NBC News
Aug 8, 2023 · The popular obesity drug Wegovy cuts the risk of cardiovascular events, such as heart attack and stroke, by 20%, drugmaker Novo Nordisk said Tuesday. The findings are the first to demonstrate...
Weight-loss drug Wegovy produces ‘largest benefit ever seen’ …
Aug 25, 2023 · The study of 529 patients, funded by drugmaker Novo Nordisk, found that a 2.4-milligram weekly dose of semaglutide, sold as Wegovy for weight loss, led to an improvement of 17 points on a...
Wegovy users keep weight off for 4 years, new analysis finds - NBC News
May 14, 2024 · Reuters. Patients taking Novo Nordisk’s Wegovy obesity treatment maintained an average of 10% weight loss after four years, potentially boosting the drugmaker’s case to insurers and governments...
Why weight-loss drug Wegovy shows promise for heart disease - NBC News
Nov 11, 2023 · The weight-loss drug Wegovy can reduce the risk of heart attacks and strokes by 20% in adults with heart disease and obesity, according to new research. The trial is the first to show that a ...
Wegovy approved to lessen heart attack, stroke risk in overweight ...
Mar 8, 2024 · The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in...
Trial confirms heart benefits of Wegovy, but is weight loss ... - CNN
Nov 11, 2023 · Results from a landmark clinical trial this summer suggested, for the first time, that a medication given for weight loss alone could reduce the risk of heart attack, stroke or heart-related...
Novo's Wegovy shows heart benefit alongside weight loss in trial
COPENHAGEN/LONDON, Aug 8 (Reuters) - Wegovy maker Novo Nordisk (NOVOb.CO) said on Tuesday a large study had shown the highly effective obesity treatment also had a clear cardiovascular benefit,...
Wegovy's heart benefits due to more than weight loss, Novo says
PHILADELPHIA, Nov 11 (Reuters) - Novo Nordisk (NOVOb.CO) on Saturday said the heart protective benefits of its wildly popular Wegovy obesity treatment are due to more than weight loss alone,...